Amyris Inc. (NASDAQ: AMRS): Is It A Buying Opportunity Again?

After Hours

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. After-hours trades for Amyris Inc. (AMRS) shows that investor sentiment remained broken, with the stock’s consolidated last price falling by -$0.15, or -4.44%, to $3.23. Volume reached 26,092 shares, with price reaching a high of $3.25 and a low of $3.2. The stock was recently discussed on Yahoo Finance as it revealed that AMYRIS TO PARTICIPATE AT SEPTEMBER INVESTOR CONFERENCES.


Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now.

Sponsored

Stocks Info

AMRS belongs to the Basic Materials sector of the NASDAQ while operating in the Specialty Chemicals industry. At the end of the last regular session, the stock closed at $3.22 and fluctuated between $3.4200 as its day high and $3.1500 as its day low. The current market capitalization of Amyris Inc. is $1.11B. A total of 4.67 million shares were traded on the day, compared to an average of 7.36M shares.

Insider Activity

Investors also take into account insider trades in predicting how the stock will perform in the future. During the recent three months, AMRS has seen 10 BUY and 3 SELL insider trades, representing the acquisition of 737,155 and the disposition of 149,609 shares. Over the last 12 months, there were 22 BUYs and 7 SELLs from insiders. Insiders purchased 902,394 shares during that period but sold 199,225.

In the most recent transaction, Kung Frank sold 200,000 shares of AMRS for 3.50 per share on Sep 21. After the transaction, the Director now owns 0 company shares. In a previous transaction on Sep 20, Kung Frank sold 400,000 shares at 3.60 per share. AMRS shares that Director owns now total 36,488.

Among the insiders who sold shares, Kung Frank disposed of 1,080,676 shares on Sep 19 at a per-share price of $3.80. This resulted in the Director holding 109,460 shares of AMRS after the transaction. In another insider transaction, Kung Frank sold 833,100 shares at $3.60 per share on Sep 16. Company shares held by the Director now total 306,608.

While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. According to analysts who have offered 12-month price targets for AMRS in the last 3 months, the mean price target is $9.31 with high estimates of $22.00 and low estimates of $2.00. In terms of 52-week highs and lows, AMRS has a high of $15.12 and a low of $1.47.

As of this writing, AMRS has an earnings estimate of $-0.22 per share for the current quarter. EPS was calculated based on a consensus of 2 estimates, with a high estimate of $-0.1 per share and a lower estimate of $-0.35. The company reported an EPS of $-0.46 in the last quarter, which was -9.52% lower than expectations of $-0.42.

Balance Sheet Annually/Quarterly

An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information.

Analysts Opinion

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 7 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for AMRS is Overweight with a score of 4.00. A total of 4 analysts rated the stock as Buy while 0 rated it as Overweight while 3 rated it as Hold. Among the other participants, 0 thought the stock was Underweight and 0 thought it should be Sold.

Related Articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest Articles

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

The 5 Best Inflation Stocks for 2022

292
294

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

The 5 Best Inflation Stocks for 2022

100% free. stop anytime no spam

Get our free report on the stocks that we recommend for investors who want to protect their portfolios from inflation.